Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function

被引:23
|
作者
Bae, Sunjae [1 ,2 ,3 ]
Wang, Jacqueline M. Garonzik [3 ]
Massie, Allan B. [1 ,3 ]
Jackson, Kyle R. [3 ]
McAdams-DeMarco, Mara A. [1 ,3 ]
Brennan, Daniel C. [4 ]
Lentine, Krista L. [5 ]
Coresh, Josef [1 ,2 ,4 ]
Segev, Dorry L. [1 ,3 ]
机构
[1] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] St Louis Univ, Ctr Abdominal Transplantat, St Louis, MO 63103 USA
来源
关键词
RENAL-TRANSPLANTATION; ACUTE REJECTION; CORTICOSTEROID AVOIDANCE; MYCOPHENOLATE-MOFETIL; RISK; IMMUNOSUPPRESSION; REGIMEN; TRIAL; MULTICENTER; PREDNISONE;
D O I
10.1681/ASN.2019040416
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Early steroid withdrawal (ESW) is associated with acceptable outcomes in kidney transplant (KT) recipients. Recipients with delayed graft function (DGF), however, often have a suboptimal allograft milieu, which may alter the risk/benefit equation for ESW. This may contribute to varying practices across transplant centers. Methods Using the Scientific Registry of Transplant Recipients, we studied 110,019 adult deceased-donor KT recipients between 2005 and 2017. We characterized the association of DGF with the use of ESW versus continued steroid maintenance across KT centers, and quantified the association of ESW with acute rejection, graft failure, and mortality using multivariable logistic and Cox regression with DGF-ESW interaction terms. Results Overall 29.2% of KT recipients underwent ESW. Recipients with DGF had lower odds of ESW (aOR=( 0.60)0.67(0.75)). The strength of this association varied across 261 KT centers, with center-specific aOR of <0.5 at 31 (11.9%) and >1.0 at 22 (8.4%) centers. ESW was associated with benefits and harms among recipients with immediate graft function (IGF), but only with harms among recipients with DGF. ESW was associated with increased acute rejection (aOR= (1.09)1.16(1.23)), slightly increased graft failure (aHR= (1.01)1.06(1)(.1)(2)), but decreased mortality (aHR= (0.86)0.89(0.93)) among recipients with IGF. Among recipients with DGF, ESW was associated with a similar increase in rejection (aOR=1.12; 95% CI, 1.02 to 1.23), a more pronounced increase in graft failure (aHR=1.16; 95% CI, 1.08 to 1.26), and no improvement in mortality (aHR=1.00; 95% CI, 0.94 to 1.07). DGF-ESW interaction was statistically significant for graft failure (P=0.04) and mortality (P=0.003), but not for rejection (P=0.6). Conclusions KT centers in the United States use ESW inconsistently in recipients with DGF. Our findings suggest ESW may lead to worse KT outcomes in recipients with DGF.
引用
收藏
页码:175 / 185
页数:11
相关论文
共 50 条
  • [21] Total ischemia time and delayed graft function in recipients of deceased donor kidney transplant: a single center experience
    Al-Mahmeed, Husain
    Moniri, Saeid
    Shanab, Jaillan
    AlDewaissan, Farah
    Al-Mousawi, Mustafa
    Jamal, Mohammad
    KUWAIT MEDICAL JOURNAL, 2023, 55 (01): : 51 - 56
  • [22] Gross Morphological Score for Deceased Donor Kidneys Can Predict Delayed Graft Function in Kidney Transplant Recipients
    Mandurah, M.
    Levine, M. A.
    Sener, A.
    Luke, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 889 - 889
  • [23] Lack of Efficacy of Eculizumab for Prevention of Delayed Graft Function (DGF) in Deceased Donor Kidney Transplant Recipients.
    Heeger, P.
    Akalin, E.
    Baweja, M.
    Bloom, R.
    Florman, S.
    Haydel, B.
    Hricik, D.
    Kulkarni, S.
    Mehrotra, A.
    Patel, A.
    Poggio, E.
    Ratner, L.
    Schroppel, S.
    Shapiro, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 674 - 674
  • [24] A Prognostic Model to Identify Deceased Donor Kidney Transplant Recipients at High Risk for Delayed Graft Function.
    Kawakita, S.
    Beaumont, J. L.
    Everly, M. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 645 - 646
  • [25] The effect of intraoperative inosine infusion on transplant outcomes in deceased-donor kidney transplant recipients
    Luo, You
    Zhang, Yang
    Tang, Zuofu
    Zhang, Jinhua
    Na, Ning
    Xiao, Hengjun
    RENAL FAILURE, 2024, 46 (02)
  • [26] Impact of deceased-donor characteristics on early graft function: outcome of kidney donor pairs accepted for transplantation
    Mahler, Christoph F.
    Friedl, Felix
    Nusshag, Christian
    Speer, Claudius
    Benning, Louise
    Goeth, Daniel
    Schaier, Matthias
    Sommerer, Claudia
    Mieth, Markus
    Mehrabi, Arianeb
    Renders, Lutz
    Heemann, Uwe
    Krautter, Markus
    Schwenger, Vedat
    Echterdiek, Fabian
    Zeier, Martin
    Morath, Christian
    Kaelble, Florian
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] Predicting Post-Transplant Graft Function in Deceased Donor Kidney Transplant Recipients.
    Archer, K.
    Zhang, Y.
    Bontha, V.
    Eason, J.
    Gallon, L.
    Akalin, F.
    Maluf, D.
    Mas, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 642 - 642
  • [28] Days of Delayed Graft Function and Its Impact on Graft Outcomes in Deceased Donor Kidney Transplant
    Budhiraja, P.
    Butterfield, R. J.
    Misra, S. S.
    Reddy, K. S.
    Kodali, L.
    Khamash, H. A.
    Nair, S.
    Mour, G. K.
    Chakkera, H. A.
    Jadlowiec, C. C.
    Janna, H.
    Heilman, R. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 651 - 652
  • [29] Delayed Graft Function and the Risk of Death With Graft Function in Living Donor Kidney Transplant Recipients
    Narayanan, Ranjit
    Cardella, Carl J.
    Cattran, Daniel C.
    Cole, Edward H.
    Tinckam, Kathryn J.
    Schiff, Jeffrey
    Kim, S. Joseph
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (05) : 961 - 970
  • [30] COSTS OF DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION IN LIVING AND DECEASED DONOR RECIPIENTS
    Crow, L.
    Cavanaugh, T. M.
    Irish, W.
    Diwan, T.
    Heaton, P.
    Succop, P.
    Eckman, M. H.
    Volek, P.
    Tan, Y.
    Boone, J.
    VALUE IN HEALTH, 2014, 17 (03) : A293 - A293